Literature DB >> 27285295

Which Amount of BMI-SDS Reduction Is Necessary to Improve Cardiovascular Risk Factors in Overweight Children?

Thomas Reinehr1, Nina Lass1, Christina Toschke1, Juliane Rothermel1, Stefanie Lanzinger1, Reinhard W Holl1.   

Abstract

CONTEXT: Knowing the changes of cardiovascular risk factors (CRFs) in relation to weight loss would be helpful to advise overweight children and their parents and to decide whether drugs should be prescribed in addition to lifestyle intervention.
OBJECTIVE: The objective of the study was to determine the body mass index (BMI)-SD score (SDS) reduction to improve CRFs in overweight children.
DESIGN: This was a prospective observation study.
SETTING: The study was conducted at a specialized outpatient obesity clinic. PATIENTS: A total of 1388 overweight children (mean BMI 27.9 ± 0.1 kg/m(2), mean age 11.4 ± 0.1 y, 43.8% male, 45.5% prepubertal) participated in the study. INTERVENTION: The study included a 1-year lifestyle intervention. MAIN OUTCOME MEASURES: We studied changes of blood pressure (BP), fasting high-density lipoprotein- and low-density lipoprotein-cholesterol, triglycerides, glucose, and homeostasis model assessment (HOMA) of insulin resistance index. Change of weight status was determined by δBMI-SDS based on the recommended percentiles of the International Task Force of Obesity.
RESULTS: BMI-SDS change was associated with a significant improvement of all CRFs except fasting glucose and low-density lipoprotein-cholesterol after adjusting for multiple confounders such as baseline CRFs, age, gender, BMI, pubertal stage, and its changes. BMI-SDS reduction of 0.25-0.5 was related to a decrease of systolic blood pressure (BP) (-3.2 ± 1.4 mm Hg), diastolic BP (-2.2 ± 1.1 mm Hg), triglycerides (-6.9 ± 5.8 mg/dL), HOMA (-0.5 ± 0.3), and triglyceride/high-density lipoprotein)-cholesterol (-0.3 ± 0.2), whereas high-density lipoprotein (HDL)-cholesterol increased (+1.3 ± 1.2 mg/dL). A reduction of greater than 0.5 BMI-SDS led to more pronounced improvement (systolic BP -6.0± 1.3 mm Hg, diastolic BP -5.1 ± 1.3 mm Hg, triglycerides -16.4 ± 7.1 mg/dL, HDL-cholesterol +1.6 ± 1.5 mg/dL, HOMA -0.9 ± 0.3). Per 0.1 BMI-SDS reduction in systolic BP (-1.0 mm Hg), diastolic BP (-0.8 mm Hg), triglycerides (-2.3 mg/dL), HOMA (-0.2), and triglyceride/HDL-cholesterol (-0.5) decreased significantly, whereas HDL-cholesterol (0.2 mg/dL) increased significantly in linear regression analyses and accounted for multiple confounders.
CONCLUSIONS: A BMI-SDS reduction of 0.25 or greater significantly improved hypertension, hypertriglyceridemia, and low HDL-cholesterol, whereas a BMI-SDS greater than 0.5 doubled the effect.

Entities:  

Mesh:

Year:  2016        PMID: 27285295     DOI: 10.1210/jc.2016-1885

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  39 in total

1.  Review of 100% Fruit Juice and Chronic Health Conditions: Implications for Sugar-Sweetened Beverage Policy.

Authors:  Brandon J Auerbach; Sepideh Dibey; Petra Vallila-Buchman; Mario Kratz; James Krieger
Journal:  Adv Nutr       Date:  2018-03-01       Impact factor: 8.701

Review 2.  Fruit Juice and Change in BMI: A Meta-analysis.

Authors:  Brandon J Auerbach; Fred M Wolf; Abigail Hikida; Petra Vallila-Buchman; Alyson Littman; Douglas Thompson; Diana Louden; Daniel R Taber; James Krieger
Journal:  Pediatrics       Date:  2017-03-23       Impact factor: 7.124

3.  Cumulative Effect of Obesogenic Behaviours on Adiposity in Spanish Children and Adolescents.

Authors:  Helmut Schröder; Rowaedh Ahmed Bawaked; Lourdes Ribas-Barba; Maria Izquierdo-Pulido; Blanca Roman-Viñas; Montserrat Fíto; Lluis Serra-Majem
Journal:  Obes Facts       Date:  2017-12-06       Impact factor: 3.942

Review 4.  Metabolic Syndrome in Children and Adolescents: Diagnostic Criteria, Therapeutic Options and Perspectives.

Authors:  Paul Weihe; Susann Weihrauch-Blüher
Journal:  Curr Obes Rep       Date:  2019-12

5.  Untargeted metabolomics identifies a plasma sphingolipid-related signature associated with lifestyle intervention in prepubertal children with obesity.

Authors:  M J Leal-Witt; M Ramon-Krauel; S Samino; M Llobet; D Cuadras; J C Jimenez-Chillaron; O Yanes; C Lerin
Journal:  Int J Obes (Lond)       Date:  2017-08-17       Impact factor: 5.095

6.  Psychosocial Pretreatment Predictors of Weight Control: A Systematic Review Update.

Authors:  Eliana V Carraça; Inês Santos; Jutta Mata; Pedro J Teixeira
Journal:  Obes Facts       Date:  2018-02-14       Impact factor: 3.942

7.  Executive Function and Dysregulated Eating Behaviors in Pediatric Obesity.

Authors:  Marissa A Gowey; Crystal S Lim; Gareth R Dutton; Janet H Silverstein; Marilyn C Dumont-Driscoll; David M Janicke
Journal:  J Pediatr Psychol       Date:  2018-09-01

8.  Transition to Self-Management among Adolescents with Polycystic Ovary Syndrome: Parent and Adolescent Perspectives.

Authors:  Cara C Young; Lynn Rew; Maria Monge
Journal:  J Pediatr Nurs       Date:  2019-05-09       Impact factor: 2.145

9.  Sustainable weight loss over three years in children with obesity: a pragmatic family-centered lifestyle intervention.

Authors:  Rasmus Møller Jørgensen; Jens Meldgaard Bruun; Britta Kremke; Rikke Frederiksen Bahnsen; Bent Windelborg Nielsen; Esben Thyssen Vestergaard
Journal:  Eat Weight Disord       Date:  2020-03-13       Impact factor: 4.652

10.  Hypothalamic Obesity: 4 Years of the International Registry of Hypothalamic Obesity Disorders.

Authors:  Susan R Rose; Vincent E Horne; Nathan Bingham; Todd Jenkins; Jennifer Black; Thomas Inge
Journal:  Obesity (Silver Spring)       Date:  2018-10-08       Impact factor: 5.002

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.